AgomAb Therapeutics N.V. (AGMB)
$9.08-1.52%Close
SELL
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $447M
- Beta
- 1.80
- P/E (TTM)
- -9.94
- Short % float
- 2.76%
- Days to cover
- 7.1
- SI change
- +15.4%
- 1W
- +6.07%
- 1M
- -34.86%
- vs SPY 1W
- +4.91%
- vs SPY 1M
- -37.86%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on AGMB?
- LOPJLB’s latest quantitative signal on AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is SELL. Signals are updated daily.
- What market regime is AGMB in?
- LOPJLB classifies each ticker into BULL, RECOVERY, BEAR, or CRISIS regimes using a Hidden Markov Model.
- What does AgomAb Therapeutics N.V. American Depositary Shares (AGMB) do?
- AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally admini…